8-KShareholder Matters

ABBOTT LABORATORIES 8-K Report, Shareholder Vote Results (May 4, 2016)

Filed May 4, 2016For Securities:ABT

Summary

Abbott Laboratories filed an 8-K report on May 4, 2016, detailing the outcomes of its Annual Meeting of Shareholders held on April 29, 2016. The primary focus of the report is the voting results on key corporate governance matters. Shareholders overwhelmingly re-elected all nominated directors to the Board and ratified the appointment of Ernst & Young LLP as the company's independent auditor. Additionally, the compensation of named executive officers received significant approval from shareholders in an advisory vote.

Key Highlights

  • 1All incumbent directors were re-elected to the Board of Directors with strong majority support.
  • 2The appointment of Ernst & Young LLP as Abbott's independent auditor for the upcoming fiscal year was ratified.
  • 3Shareholders provided advisory approval for the compensation of Abbott's named executive officers, with 94.01% of votes cast in favor.
  • 4The filing serves as official notification of the voting outcomes from the Annual Meeting of Shareholders.
  • 5Broker non-votes were noted for the director elections and executive compensation proposal, indicating shares held by brokers that were not voted on these specific matters.
  • 6The voting results demonstrate shareholder confidence in the current board and executive compensation structure.

Frequently Asked Questions

The main topics voted on included the election of the Board of Directors, the ratification of Ernst & Young LLP as the company's independent auditor, and an advisory vote on the compensation of named executive officers.

Shareholders overwhelmingly voted to re-elect all nominated directors to the Board. For each director, the number of 'Votes For' significantly exceeded 'Votes Withheld' and 'Broker Non-Votes'.

Yes, shareholders ratified the appointment of Ernst & Young LLP as Abbott's independent auditors with a substantial majority of votes in favor.

The compensation of Abbott's named executive officers was approved by shareholders on an advisory, non-binding basis. 94.01 percent of the votes cast were in favor of the proposal.